Bayer S.A.

Non-Quoted Public Company
Rua Domingos Jorge 1100, 10 andar, Socorro, Sao Paulo,  04779-900, Brazil
()55 11 5694 6536, 55 11 5694 5596 fax, http://www.bayer.com.br

Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Manufacture and distribution of chemicals, agricultural chemicals, pharmaceuticals, veterinary products, coatings rubber, plastics, synthetic fibres and photographic materials. The company has 3 divisions; Bayer Healthcare, Bayer CropScience, Bayer MaterialScience

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Bayer S.A., News and Information

Flemish researchers develop revolutionary technology for use in plant breeding.
NewsRx Health & Science; 11/22/2009; 584 words; ...production is strongly related to its epigenetic code. By using a 'smart' selection adapting the epigenetic code, Bayer BioScience's hope is to use the technology in breeding and to develop improved yield varieties. Using this method in rapeseed...

This Global Outlook Series on Genetic Engineering Provides a Collection of Market Briefs and Concise Summaries of Research Findings.
Gene Therapy Weekly; 11/19/2009; 1522 words; ...Factors Influencing Gene Therapy's Future Development Factors Hampering...mAbs New Study Reveals microRNA's Role in Heart Failure Cell-based...Acquires DNA Diagnostic Center Bayer HealthCare Takes Over Direvo Biotech...USDA to Deregulate Syngenta's GE Corn Archer Daniels, Deere...

CHI Gathers Biomedical Community for the California Healthcare Policy Forum.
Blood Weekly; 11/19/2009; 982 words; ...president, specialty medicine, Bayer HealthCare LLC; Robert B. Hance...tomorrow," said Martin, CHI's chairman. CHI thanks its sponsors...research organizations. CHI's mission is to advance responsible...promote scientific discovery. CHI's Web site is www.chi.org...

Maxygen Reports Third Quarter 2009 Financial Results.(Financial report)
Blood Weekly; 11/19/2009; 1222 words; ...Perseid Therapeutics LLC, the company's joint venture with Astellas Pharma Inc., and Maxygen's subsequent restructuring. The net income...connection with the sale of the company's hematology assets to Bayer HealthCare LLC. Revenue for the third...

genOway acquires exclusive license for Flex technology developed by Professor Pierre Chambon and Dr. Norbert Ghyselinck at the IGBMC.
Blood Weekly; 11/19/2009; 1408 words; ...and customer portfolios. The company's development is founded upon both a broad...of the pharmaceutical industry (Pfizer, Bayer, Boehringer Ingelheim, etc.), and with...prestigious academic research centers (King's College! and the University of Manchester...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.